Temozolomide (TMZ) CAS 85622-93-1 Assay 99.0%~101.0% API Factory High Purity

Apejuwe kukuru:

Orukọ Kemikali: Temozolomide (TMZ)

CAS: 85622-93-1

Irisi: Funfun si Light Pink Powder

Ayẹwo: 99.0% ~ 101.0%

Temozolomide jẹ oluranlowo alkylating ẹnu ti a lo lati tọju Glioblastoma Multiforme (GBM) ati Astrocytomas, Metastatic Melanoma.

API Didara Giga, Iṣelọpọ Iṣowo

Inquiry: alvin@ruifuchem.com


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Kemikali Properties:

Orukọ Kemikali Temozolomide
Awọn itumọ ọrọ sisọ 3,4-Dihydro-3-Methyl-4-Oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-Carboxamide
Nọmba CAS 85622-93-1
NỌMBA CAT RF-API29
Iṣura Ipo Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Fọọmu Molecular C6H6N6O2
Òṣuwọn Molikula 194.15
Ojuami Iyo 212 ℃ Oṣu kejila.
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Funfun to Light Pink lulú
Idanimọ Nipasẹ IR, HPLC
Awọn ohun elo ti o ku Dimethyl Sulphoxide ≤0.50%
Awọn nkan ti o jọmọ
AIC aimọ ≤0.10%
Aimọ Kanṣoṣo ≤0.10%
Isinmi Aimọ Egbin ≤0.30%
Lapapọ Awọn Aimọ ≤0.30%
Awọn irin Heavy ≤10ppm
Pipadanu lori Gbigbe ≤0.50%
Aloku lori Iginisonu ≤0.10%
Ayẹwo 99.0% ~ 101.0% (HPLC lori ipilẹ gbigbẹ)
Igbeyewo Standard Standard Enterprise
Lilo Ohun elo elegbogi ti nṣiṣe lọwọ (API)

Package & Ibi ipamọ:

Package: Igo, apo apamọwọ Aluminiomu, ilu paali, 25kg / Drum, tabi gẹgẹbi ibeere alabara.

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin ati kokoro infestation.

Awọn anfani:

1

FAQ:

Ohun elo:

Shanghai Ruifu Chemical Co., Ltd jẹ olupilẹṣẹ asiwaju ati olupese ti Temozolomide (CAS: 85622-93-1) pẹlu didara to gaju.Temozolomide (TMZ) jẹ oluranlowo alkylating ẹnu ti a lo lati ṣe itọju Glioblastoma Multiforme (GBM) ati Astrocytomas, Metastatic Melanoma.

Temozolomide jẹ imunadoko akọkọ ti ẹnu ti a mu imidazole ati oogun anticancer kilasi tetrazine eyiti o jẹ ti iran keji ti oluranlowo alkylating pẹlu iṣẹ antitumor laisi imuṣiṣẹ iṣelọpọ ti ẹdọ lẹhin iṣakoso ẹnu.O jẹ ijuwe nipasẹ titẹ sii ni irọrun nipasẹ idena ọpọlọ-ẹjẹ, ifarada ti o dara ati pe ko ni fifẹ pẹlu majele ti awọn oogun miiran, ati nini ipa synergistic pẹlu radiotherapy eyiti o dara fun atọju isodipupo glioma buburu lẹhin itọju aṣa gẹgẹbi awọn èèmọ glioblastoma multiforme tabi astrocytoma degenerative.O jẹ oogun laini akọkọ fun itọju melanoma metastatic.

Temozolomide ti ni iṣakojọpọ akọkọ nipasẹ Ẹgbẹ Iwadi Cancer UK, ati lẹhinna gbe lọ si Ile-iṣẹ Schering-Plough (Amẹrika) fun idagbasoke.O ni eto kemikali aramada ati pe o jẹ ti itọsẹ mẹrin-imidazole.Ni ọdun 1999, o ti fọwọsi fun titẹ si ọja ni EU ati AMẸRIKA nibiti itọkasi idasilẹ ni Amẹrika jẹ pataki fun itọju ila-keji ti glioblastoma multiforme ati gliomas irawọ degenerative ati awọn itọkasi ti EU jẹ fun atọju idagbasoke tabi ifasẹyin glioblastoma multiforme. eyi ti o ti wa tẹlẹ koko ọrọ si mora ailera.Ipa ti temozolomide lori itọju glioblastoma multiforme ti gba idanimọ diẹ sii ni Yuroopu.

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa